In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.
“More strictly designed clinical trial studies are needed to replicate this finding,” said Kai Wang, first author, PhD, of Harvard University.
Full bibliographic information
Wang, K, Gerke, TA, Chen, X, Prosperi, M. Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine. 2019; 00: 1– 9. .